Werewolf Therapeutics Inc... (HOWL)

AI Score

Unlock

0.91

0.06 (6.51%)

At close: Apr 24, 2025, 3:59 PM

0.89

-2.51%

After-hours: Apr 24, 2025, 04:38 PM EDT

Dividends

No dividend history available for Werewolf Therapeutics Inc..

Pro Subscription

Upgrade now for unlimited access to all data and tools.

Dividend Definition

Dividends are payments made by a company to its shareholders, typically derived from its profits. They represent a portion of earnings distributed to investors as a reward for holding shares. Dividends do not account for retained earnings or reinvestments and are therefore different from a company's total profits.

Full Definition

Related Stocks

Company	Dividend Yield
Third Harmonic Bio	2.71%

Dividend Rankings

HOWL News

8 months ago · Werewolf Therapeutics, Inc. (HOWL) Reports Q2 Loss, Lags Revenue Estimates - zacks.com
1 year ago · All You Need to Know About Werewolf Therapeutics (HOWL) Rating Upgrade to Buy - zacks.com
1 year ago · Werewolf Therapeutics: In The Hunt For Success In The Cytokine Space - seekingalpha.com
1 year ago · How Much Upside is Left in Werewolf Therapeutics, Inc. (HOWL)? Wall Street Analysts Think 92.37% - zacks.com
1 year ago · Werewolf Therapeutics, Inc. (HOWL) Reports Q4 Loss, Lags Revenue Estimates - zacks.com
1 year ago · Werewolf Therapeutics: Still In The Race To Develop Next Generation Cytokines - seekingalpha.com
1 year ago · Werewolf Therapeutics: Possibly A Transformative IL-2, But Still Early Days - seekingalpha.com
1 year ago · Why Is Werewolf Therapeutics (HOWL) Stock Up 20% Today? - investorplace.com
1 year ago · Werewolf: Q4 2023 Data Readout And Enhancement Of Validated Targets - seekingalpha.com
1 year ago · Werewolf Therapeutics, Inc. (HOWL) Reports Q2 Loss, Tops Revenue Estimates - zacks.com